DNA analysis in inherited cardiomyopathies: Current status and clinical relevance

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue SUPPL. 1, 2008, Pages

  Van Spaendonck Zwarts, Karin Y ^a   Van Den Berg, Maarten P ^a   Van Tintelen, J Peter ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cardiomyopathy; Clinical relevance; DNA analysis; Genetics

Indexed keywords

ANTIARRHYTHMIC AGENT; DESMOCOLLIN; DESMOGLEIN; DESMOPLAKIN; PLAKOGLOBIN; PLAKOPHILIN;

CARDIOMYOPATHY; CARDIOVASCULAR RISK; CELL NUCLEUS MEMBRANE; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; CYTOSKELETON; DECISION MAKING; DESMOSOME; DNA DETERMINATION; FAMILY; GENE MUTATION; GENOTYPE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; PHENOTYPE; SARCOMERE; SCREENING; WOLFF PARKINSON WHITE SYNDROME;

CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CLINICAL TRIALS AS TOPIC; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 38449123322     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.00956.x     Document Type: Conference Paper

References (14)

1. Binder J, Ommen SR, Gersh BJ, Van Driest SL, Tajik AJ, Nishimura RA, Ackerman MJ. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: Septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 2006 81 : 459 467.
2. Alders M, Jongbloed R, Deelen W, Van den Wijngaard A, Doevendans P, Ten Cate F, Regitz-Zagrosek V, et al. The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J 2003 24 : 1848 1853.
3. Arens YH, Hermans JF, Kuusisto J, Jaaskelainen P, Chai W, Wilde AA, Pinto YM. Can electrocardiographic changes help to identify the causative mutation in hereditary hypertrophic cardiomyopathy? Suppl Circul 2005 112 : II 604.
4. Richard P, Villard E, Charron P, Isnard R. The genetic bases of cardiomyopathies. J Am Coll Cardiol 2006 48 : A79 A89.
5. Van Driest SL, Ackerman MJ, Ommen SR, Shakur R, Will ML, Nishimura RA, Tajik AJ, et al. Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy. Circulation 2002 106 : 3085 3090.
6. Murphy RT, Starling RC. Genetics and cardiomyopathy: Where are we now? Cleve Clin J Med 2005 72 : 465 483.
7. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharm P, McDonough B, Smoot L, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000 7 343 : 1688 1696.
8. Van Berlo JH, de Voogt WG, Van Der Kooi AJ, Van Tintelen JP, Bonne G, Ben Yaou R, Duboc D, et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: Do lamin A/C mutations portend a high risk of sudden death? J Mol Med 2005 83 : 79 83.
9. McNair WP, Ku L, Taylor MR, Fain PR, Dao D, Wolfel E, Mestroni L et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004 110 : 2163 2167.
10. Meune C, Van Berlo JH, Anselme F, Bonne G, Pinto YP, Duboc D. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006 12 354 : 209 210.
11. van Tintelen JP, Hofstra RM, Wiesfeld AC, Van den Berg MP, Hauer RNW, Jongbloed JDH. Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: Emerging horizon? Curr Opin Cardiol 2007 22 : 185 192.
12. Dalal D, James C, Devanagondi R, Tichnell C, Tucker A, Prakasa K, Spevak PJ, et al. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2006 48 : 1416 1424.
13. van Tintelen JP, Entius MM, Bhuiyan ZA, Jongbloed R, Wiesfeld ACP, Wilde AAM, Van der Smagt J, et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2006 113 : 1650 1658.
14. Hodgkinson KA, Parfrey PS, Bassett AS, Kupprion C, Drenkhahn J, Norman MW, Thierfelder L, et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 2005 45 : 4000 4008.